The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Gene Editing Service Market Research Report 2025

Global Gene Editing Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1720154

No of Pages : 97

Synopsis

Genome editing, or genome engineering, or gene editing, is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism.

The global Gene Editing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Gene Editing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Gene Editing Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Gene Editing Service in Commercial is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Gene Editing Service include Caribou Biosciences, CRISPR Therapeutics, Merck KGaA, Editas Medicine, Thermo Fisher Scientific, Horizon Discovery, Genscript Biotech, GeneCopoeia and Integrated DNA Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Gene Editing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Editing Service.

Report Scope

The Gene Editing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Editing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Editing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Caribou Biosciences
  • CRISPR Therapeutics
  • Merck KGaA
  • Editas Medicine
  • Thermo Fisher Scientific
  • Horizon Discovery
  • Genscript Biotech
  • GeneCopoeia
  • Integrated DNA Technologies
  • Eurofins Genomics
  • DNA 2.0 (ATUM)
  • BBI Life Sciences
  • Genewiz
  • Gene Oracle
  • SBS Genetech
  • Bio Basic

Segment by Type

  • Ex-Vivo
  • In-Vivo

Segment by Application

  • Commercial
  • Academic Research

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Editing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Ex-Vivo
1.2.3 In-Vivo
1.3 Market by Application
1.3.1 Global Gene Editing Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Academic Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Editing Service Market Perspective (2019-2030)
2.2 Gene Editing Service Growth Trends by Region
2.2.1 Global Gene Editing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Editing Service Historic Market Size by Region (2019-2024)
2.2.3 Gene Editing Service Forecasted Market Size by Region (2025-2030)
2.3 Gene Editing Service Market Dynamics
2.3.1 Gene Editing Service Industry Trends
2.3.2 Gene Editing Service Market Drivers
2.3.3 Gene Editing Service Market Challenges
2.3.4 Gene Editing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Editing Service Players by Revenue
3.1.1 Global Top Gene Editing Service Players by Revenue (2019-2024)
3.1.2 Global Gene Editing Service Revenue Market Share by Players (2019-2024)
3.2 Global Gene Editing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Editing Service Revenue
3.4 Global Gene Editing Service Market Concentration Ratio
3.4.1 Global Gene Editing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Service Revenue in 2023
3.5 Gene Editing Service Key Players Head office and Area Served
3.6 Key Players Gene Editing Service Product Solution and Service
3.7 Date of Enter into Gene Editing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Editing Service Breakdown Data by Type
4.1 Global Gene Editing Service Historic Market Size by Type (2019-2024)
4.2 Global Gene Editing Service Forecasted Market Size by Type (2025-2030)
5 Gene Editing Service Breakdown Data by Application
5.1 Global Gene Editing Service Historic Market Size by Application (2019-2024)
5.2 Global Gene Editing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Editing Service Market Size (2019-2030)
6.2 North America Gene Editing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Editing Service Market Size by Country (2019-2024)
6.4 North America Gene Editing Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Editing Service Market Size (2019-2030)
7.2 Europe Gene Editing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Editing Service Market Size by Country (2019-2024)
7.4 Europe Gene Editing Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Editing Service Market Size (2019-2030)
8.2 Asia-Pacific Gene Editing Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Editing Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Editing Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Editing Service Market Size (2019-2030)
9.2 Latin America Gene Editing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Editing Service Market Size by Country (2019-2024)
9.4 Latin America Gene Editing Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Editing Service Market Size (2019-2030)
10.2 Middle East & Africa Gene Editing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Editing Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Editing Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Detail
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences Gene Editing Service Introduction
11.1.4 Caribou Biosciences Revenue in Gene Editing Service Business (2019-2024)
11.1.5 Caribou Biosciences Recent Development
11.2 CRISPR Therapeutics
11.2.1 CRISPR Therapeutics Company Detail
11.2.2 CRISPR Therapeutics Business Overview
11.2.3 CRISPR Therapeutics Gene Editing Service Introduction
11.2.4 CRISPR Therapeutics Revenue in Gene Editing Service Business (2019-2024)
11.2.5 CRISPR Therapeutics Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Gene Editing Service Introduction
11.3.4 Merck KGaA Revenue in Gene Editing Service Business (2019-2024)
11.3.5 Merck KGaA Recent Development
11.4 Editas Medicine
11.4.1 Editas Medicine Company Detail
11.4.2 Editas Medicine Business Overview
11.4.3 Editas Medicine Gene Editing Service Introduction
11.4.4 Editas Medicine Revenue in Gene Editing Service Business (2019-2024)
11.4.5 Editas Medicine Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Gene Editing Service Introduction
11.5.4 Thermo Fisher Scientific Revenue in Gene Editing Service Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Horizon Discovery
11.6.1 Horizon Discovery Company Detail
11.6.2 Horizon Discovery Business Overview
11.6.3 Horizon Discovery Gene Editing Service Introduction
11.6.4 Horizon Discovery Revenue in Gene Editing Service Business (2019-2024)
11.6.5 Horizon Discovery Recent Development
11.7 Genscript Biotech
11.7.1 Genscript Biotech Company Detail
11.7.2 Genscript Biotech Business Overview
11.7.3 Genscript Biotech Gene Editing Service Introduction
11.7.4 Genscript Biotech Revenue in Gene Editing Service Business (2019-2024)
11.7.5 Genscript Biotech Recent Development
11.8 GeneCopoeia
11.8.1 GeneCopoeia Company Detail
11.8.2 GeneCopoeia Business Overview
11.8.3 GeneCopoeia Gene Editing Service Introduction
11.8.4 GeneCopoeia Revenue in Gene Editing Service Business (2019-2024)
11.8.5 GeneCopoeia Recent Development
11.9 Integrated DNA Technologies
11.9.1 Integrated DNA Technologies Company Detail
11.9.2 Integrated DNA Technologies Business Overview
11.9.3 Integrated DNA Technologies Gene Editing Service Introduction
11.9.4 Integrated DNA Technologies Revenue in Gene Editing Service Business (2019-2024)
11.9.5 Integrated DNA Technologies Recent Development
11.10 Eurofins Genomics
11.10.1 Eurofins Genomics Company Detail
11.10.2 Eurofins Genomics Business Overview
11.10.3 Eurofins Genomics Gene Editing Service Introduction
11.10.4 Eurofins Genomics Revenue in Gene Editing Service Business (2019-2024)
11.10.5 Eurofins Genomics Recent Development
11.11 DNA 2.0 (ATUM)
11.11.1 DNA 2.0 (ATUM) Company Detail
11.11.2 DNA 2.0 (ATUM) Business Overview
11.11.3 DNA 2.0 (ATUM) Gene Editing Service Introduction
11.11.4 DNA 2.0 (ATUM) Revenue in Gene Editing Service Business (2019-2024)
11.11.5 DNA 2.0 (ATUM) Recent Development
11.12 BBI Life Sciences
11.12.1 BBI Life Sciences Company Detail
11.12.2 BBI Life Sciences Business Overview
11.12.3 BBI Life Sciences Gene Editing Service Introduction
11.12.4 BBI Life Sciences Revenue in Gene Editing Service Business (2019-2024)
11.12.5 BBI Life Sciences Recent Development
11.13 Genewiz
11.13.1 Genewiz Company Detail
11.13.2 Genewiz Business Overview
11.13.3 Genewiz Gene Editing Service Introduction
11.13.4 Genewiz Revenue in Gene Editing Service Business (2019-2024)
11.13.5 Genewiz Recent Development
11.14 Gene Oracle
11.14.1 Gene Oracle Company Detail
11.14.2 Gene Oracle Business Overview
11.14.3 Gene Oracle Gene Editing Service Introduction
11.14.4 Gene Oracle Revenue in Gene Editing Service Business (2019-2024)
11.14.5 Gene Oracle Recent Development
11.15 SBS Genetech
11.15.1 SBS Genetech Company Detail
11.15.2 SBS Genetech Business Overview
11.15.3 SBS Genetech Gene Editing Service Introduction
11.15.4 SBS Genetech Revenue in Gene Editing Service Business (2019-2024)
11.15.5 SBS Genetech Recent Development
11.16 Bio Basic
11.16.1 Bio Basic Company Detail
11.16.2 Bio Basic Business Overview
11.16.3 Bio Basic Gene Editing Service Introduction
11.16.4 Bio Basic Revenue in Gene Editing Service Business (2019-2024)
11.16.5 Bio Basic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’